RAFAEL
SAN JUAN GARRIDO
Profesor asociado de Ciencias de la Salud
MANUEL
LIZASOAÍN HERNÁNDEZ
Profesor asociado de Ciencias de la Salud
Publications dans lesquelles il/elle collabore avec MANUEL LIZASOAÍN HERNÁNDEZ (27)
2023
-
Nirmatrelvir/ritonavir for the treatment of immunocompromised adult patients with early-stage symptomatic COVID-19: A real-life experience
Journal of Medical Virology, Vol. 95, Núm. 9
-
Production of OXA-48 carbapenemase acts as an independent risk factor for poor outcome in Klebsiella pneumoniae infection
European Journal of Clinical Microbiology and Infectious Diseases, Vol. 42, Núm. 12, pp. 1485-1497
2022
-
A predictive score at admission for respiratory failure among hospitalized patients with confirmed 2019 Coronavirus Disease: a simple tool for a complex problem
Internal and Emergency Medicine, Vol. 17, Núm. 2, pp. 515-524
-
Analysis of the factors predicting clinical response to tocilizumab therapy in patients with severe COVID-19
International Journal of Infectious Diseases, Vol. 117, pp. 56-64
-
Derivation of a score to predict infection due to multidrug-resistant Pseudomonas aeruginosa: a tool for guiding empirical antibiotic treatment
Journal of Global Antimicrobial Resistance, Vol. 29, pp. 215-221
-
Effectiveness of ceftazidime-avibactam for the treatment of infections due to Pseudomonas aeruginosa
International Journal of Antimicrobial Agents, Vol. 59, Núm. 2
-
Prognostic factors of OXA-48 carbapenemase-producing Klebsiella pneumoniae infection in a tertiary-care Spanish hospital: A retrospective single-center cohort study
International Journal of Infectious Diseases, Vol. 119, pp. 59-68
-
Risk Factors and Outcomes for Multidrug Resistant Pseudomonas aeruginosa Infection in Immunocompromised Patients
Antibiotics, Vol. 11, Núm. 11
2021
-
Eradication of staphylococcus aureus post-sternotomy mediastinitis following the implementation of universal preoperative nasal decontamination with mupirocin: An interrupted time-series analysis
Clinical Infectious Diseases, Vol. 73, Núm. 9, pp. 1685-1692
-
Tocilizumab for the treatment of adult patients with severe COVID-19 pneumonia: A single-center cohort study
Journal of Medical Virology, Vol. 93, Núm. 2, pp. 831-842
2020
2013
-
A non-compulsory stewardship programme for the management of antifungals in a university-affiliated hospital
Clinical Microbiology and Infection, Vol. 19, Núm. 1, pp. 56-61
-
Epidemiology, risk factors and impact on long-term pancreatic function of infection following pancreas-kidney transplantation
Clinical Microbiology and Infection, Vol. 19, Núm. 12, pp. 1132-1139
-
Influence of antiviral therapy in the long-term outcome of recurrent hepatitis C virus infection following liver transplantation
Transplant Infectious Disease, Vol. 15, Núm. 4, pp. 405-415
2012
-
Aspergillus tracheobronchitis: Report of 8 cases and review of the literature
Medicine (United States), Vol. 91, Núm. 5, pp. 261-273
2011
-
Acute graft pyelonephritis in renal transplant recipients: Incidence, risk factors and long-term outcome
Nephrology Dialysis Transplantation, Vol. 26, Núm. 3, pp. 1065-1073
2010
-
Safety and efficacy of moxifloxacin monotherapy for treatment of orthopedic implant-related staphylococcal infections
Antimicrobial Agents and Chemotherapy, Vol. 54, Núm. 12, pp. 5161-5166
2009
-
Pretransplant lymphocyte count predicts the incidence of infection during the first two years after liver transplantation
Liver Transplantation, Vol. 15, Núm. 10, pp. 1209-1216
-
Value of serial quantification of fungal DNA by a real-time PCR-based technique for early diagnosis of invasive aspergillosis in patients with febrile neutropenia
Journal of Clinical Microbiology, Vol. 47, Núm. 2, pp. 379-384
2008
-
Urinary tract infection due to Corynebacterium urealyticum in kidney transplant recipients: An underdiagnosed etiology for obstructive uropathy and graft dysfunction - Results of a prospective cohort study
Clinical Infectious Diseases, Vol. 46, Núm. 6, pp. 825-830